Professional Associations

This page includes news coverage of medical associations and medical societies. Use these links to find focused news coverage from specific organizations: Cardiology Associations, Healthcare Associations, Radiology Associations.

Researchers use multi-modality imaging to learn more about MINOCA
The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.
FDA approves 2 implantable heart devices from Biotronik
These devices were built to provide better patient data and improve clinician workflows. They will be on display at Heart Rhythm 2026 in Chicago.
Middle-aged Americans who exercise now will enjoy longer, healthier lives later
The more you maintain good physical fitness from your mid-40s to your mid-60s, the likelier you are to add years to your life and life to your later years.
Heart failure experts agree: HFmrEF should not be ignored
Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.
When bioprosthetic mitral valves fail: Redo surgery bests transcatheter treatment after 5 years
Short-term outcomes were comparable, but long-term data revealed a significant difference in all-cause mortality.

Harmony Reynolds, MD, FACC, director of the cardiovascular clinical research center at NYU Langone Health, presented a study at the American College of Cardiology (ACC) 2026 meeting using coronary optical coherence tomography (OCT) and cardiac magnetic resonance imaging (MRI) to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries (MINOCA).

Researchers use multi-modality imaging to learn more about MINOCA

The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.

The U.S. Food and Drug Administration (FDA) has granted market clearance for Biotronik's Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The new technology will be launches at the Heart Rhythm Society (HRS) annual meeting this week. #HRS2026

FDA approves 2 implantable heart devices from Biotronik

These devices were built to provide better patient data and improve clinician workflows. They will be on display at Heart Rhythm 2026 in Chicago.

Middle-aged Americans who exercise now will enjoy longer, healthier lives later

The more you maintain good physical fitness from your mid-40s to your mid-60s, the likelier you are to add years to your life and life to your later years.

doctor patient elderly check up hospital

Heart failure experts agree: HFmrEF should not be ignored

Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.

When bioprosthetic mitral valves fail: Redo surgery bests transcatheter treatment after 5 years

Short-term outcomes were comparable, but long-term data revealed a significant difference in all-cause mortality.

Christoph Wald, MD, MBA, FACR, vice chair of the American College of Radiology (ACR) Board of Chancellors, professor of radiology and senior associate consultant for radiologist at Mayo Clinic, explains the ACR resources available to radiology practices to better evaluate artificial intelligence imaging algorithms.

American College of Radiology offers cybersecurity resources

Christoph Wald, MD, vice chair of the American College of Radiology Board of Chancellors, explains the resources available to practices looking to bolster cybersecurity.

cardiologists going through the certification process

Sirolimus- and paclitaxel-coated balloons deliver comparable 1-year PCI outcomes

Researchers explored data from more than 8,000 patients treated over a three-year period.

Nicholas Marston, MD, MPH assistant professor of medicine, and a cardiologist at Brigham and Women's Hospital, presented the late-breaking VESALIUS-CV data on the use of evolocumab for the reduction of major cardiovascular events in patients who do not have significant atherosclerosis. #ACC26

Evolocumab reduces risk of major cardiac events in diabetic patients

Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial.